Celldex Therapeutics Inc (CLDX)
25.39
-0.26
(-1.01%)
USD |
NASDAQ |
Dec 27, 16:00
25.40
+0.01
(+0.04%)
After-Hours: 20:00
Celldex Therapeutics Shareholders Equity (Quarterly): 785.90M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
| Senseonics Holdings Inc | -17.18M |
| Myomo Inc | 9.292M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 823.18M |
| Total Liabilities (Quarterly) | 37.27M |
| Current Ratio | 24.27 |